{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622618c7057f3400120d15db/685a93eaf42ce01224223df2?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Novartis CEO: Medical Innovation, Tech Partnerships, and European Competitiveness","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622618c7057f3400120d15db/1750766531647-8cf7d1cf-014e-46c9-ab6f-d2462f577081.jpeg?height=200","description":"<p>Can AI help us find cures for diseases we've never been able to treat? Nicolai Tangen speaks with Vasant 'Vas' Narasimhan, CEO of&nbsp;Novartis, about pioneering pharmaceutical innovation. They explore breakthrough cell and gene therapies, AI partnerships with leading tech companies, and how&nbsp;Novartis&nbsp;transformed from a sprawling conglomerate into a streamlined drug discovery company. Vas shares his unique perspective as a physician-scientist turned CEO, his concerns about Europe's declining pharma competitiveness, and his leadership philosophy of being the 'chief energy officer.' With €235 billion in market cap and groundbreaking treatments reaching patients worldwide,&nbsp;Novartis&nbsp;continues unlocking medical breakthroughs. Tune in!</p><p>&nbsp;</p><p>In Good Company is hosted by Nicolai Tangen, CEO of Norges Bank Investment Management. New full episodes every Wednesday, and don't miss our Highlight episodes every Friday.&nbsp;</p><p>&nbsp;</p><p>The production team for this episode includes Isabelle Karlsson and PLAN-B's Niklas Figenschau Johansen, Sebastian Langvik-Hansen and Pål Huuse. Background research was conducted by Isabelle Karlsson.</p><p>&nbsp;</p><ul><li>Watch the episode on YouTube:&nbsp;<a href=\"https://www.youtube.com/@norgesbankinvestmentmanage223\" rel=\"noopener noreferrer\" target=\"_blank\"><u>Norges Bank Investment Management - YouTube</u></a></li><li>Want to learn more about the fund?&nbsp;<a href=\"https://www.nbim.no/en/\" rel=\"noopener noreferrer\" target=\"_blank\"><u>The fund | Norges Bank Investment Management (nbim.no)</u></a></li><li>Follow Nicolai Tangen on LinkedIn:&nbsp;<a href=\"https://www.linkedin.com/in/nicolai-tangen/\" rel=\"noopener noreferrer\" target=\"_blank\"><u>Nicolai Tangen | LinkedIn</u></a></li><li>Follow NBIM on LinkedIn:&nbsp;<a href=\"https://www.linkedin.com/company/12557/admin/feed/posts/\" rel=\"noopener noreferrer\" target=\"_blank\"><u>Norges Bank Investment Management: Administrator for bedriftsside | LinkedIn</u></a></li><li>Follow NBIM on Instagram:&nbsp;<a href=\"https://www.instagram.com/explore/locations/1688331664768381/norges-bank-investment-management/\" rel=\"noopener noreferrer\" target=\"_blank\"><u>Explore Norges Bank Investment Management on Instagram</u></a></li></ul>","author_name":"Norges Bank Investment Management"}